| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | $105,586 | -4,559 | -2.5% | $23.16 | 179,980 | 02 Mar 2023 | By LLC | F1, F2, F3 |
| transaction | CSTL | Common Stock | Sale | $35,203 | -1,520 | -1.6% | $23.16 | 91,260 | 02 Mar 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F2, F4 |
| transaction | CSTL | Common Stock | Sale | $35,180 | -1,519 | -1.6% | $23.16 | 91,286 | 02 Mar 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F2, F5 |
| transaction | CSTL | Common Stock | Sale | $53,050 | -2,250 | -1.3% | $23.58 | 177,730 | 02 Mar 2023 | By LLC | F1, F3, F6 |
| transaction | CSTL | Common Stock | Sale | $17,684 | -750 | -0.82% | $23.58 | 90,510 | 02 Mar 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F6 |
| transaction | CSTL | Common Stock | Sale | $17,707 | -751 | -0.82% | $23.58 | 90,535 | 02 Mar 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F6 |
| transaction | CSTL | Common Stock | Sale | $200,925 | -8,191 | -4.6% | $24.53 | 169,539 | 03 Mar 2023 | By LLC | F1, F3, F7 |
| transaction | CSTL | Common Stock | Sale | $66,967 | -2,730 | -3% | $24.53 | 87,780 | 03 Mar 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F7 |
| transaction | CSTL | Common Stock | Sale | $66,967 | -2,730 | -3% | $24.53 | 87,805 | 03 Mar 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F7 |
| holding | CSTL | Common Stock | 830 | 02 Mar 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022. |
| F2 | This transaction was executed in multiple trades at prices ranging from $22.515 to $23.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. |
| F4 | Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F5 | Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F6 | This transaction was executed in multiple trades at prices ranging from $23.520 to $23.740, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $23.965 to $24.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |